Abstract
I appreciate Dr. Munakomi's comments, on our editorial,1 about the importance of public education to increase treatment opportunities for patients with acute ischemic stroke. At the same time, research to enhance diagnostic tests is needed and might help guide the most appropriate and effective treatments. The work by Bustamante et al.2 brings us one step closer to a potential blood biomarker that may, one day, help guide therapeutic decision making in the setting of acute ischemic stroke.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
